Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms

Probable mechanisms involved in the antipsychotic-like activity of morin in mice

(2018) Benneth Ben-Azu et al.   BIOMEDICINE & PHARMACOTHERAPY

Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice

(2018) Benneth Ben-Azu et al.   BRAIN RESEARCH BULLETIN

Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells

(2018) Qi Zhang et al.   FOOD AND CHEMICAL TOXICOLOGY

Glutamate Deregulation in Ketamine-Induced Psychosis—A Potential Role of PSD95, NMDA Receptor and PMCA Interaction

(2017) Malwina Lisek et al.   Frontiers in Cellular Neuroscience

Development and characterization of morin hydrate loaded microemulsion for the management of Alzheimer’s disease

(2017) Dheeraj Sharma et al.   Artificial Cells Nanomedicine and Biotechnology

Morin hydrate mitigates rapid eye movement sleep deprivation-induced neurobehavioural impairments and loss of viable neurons in the hippocampus of mice

(2017) Elizabeth T. Olonode et al.   BEHAVIOURAL BRAIN RESEARCH

Comparison of phencyclidine-induced spatial learning and memory deficits and reversal by sertindole and risperidone between Lister Hooded and Wistar rats

(2016) Jouni Ihalainen et al.   BEHAVIOURAL BRAIN RESEARCH

Morin: A Promising Natural Drug

(2016) Anna Caselli et al.   CURRENT MEDICINAL CHEMISTRY

Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia

(2016) Ming Teng Koh et al.   SCHIZOPHRENIA RESEARCH

Regional brain dysregulation of Ca2+-handling systems in ketamine-induced rat model of experimental psychosis

(2015) Malwina Lisek et al.   CELL AND TISSUE RESEARCH

The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells

(2015) HWANG-BO HYUN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Antipsychotic activity of standardizedBacopaextract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems

(2015) Manavi Chatterjee et al.   PHARMACEUTICAL BIOLOGY

Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms

(2015) Germana Silva Vasconcelos et al.   SCHIZOPHRENIA RESEARCH

Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system

(2015) Paul S. Baxter et al.   Nature Communications

5-Hydroxytryptamine1Areceptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation

(2014) April Johnston et al.   JOURNAL OF PHYSIOLOGY-LONDON

Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats

(2014) Mohammad S. Ola et al.   NEUROLOGICAL SCIENCES

Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and β-cell function in streptozotocin-induced diabetic rats

(2013) P. Vanitha et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways

(2013) Aline Santos Monte et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Design of potent inhibitors of acetylcholinesterase using morin as the starting compound

(2013) C. Remya et al.   Frontiers in Life Science

Effects of morin-5′-sulfonic acid sodium salt (NaMSA) on cyclophosphamide-induced changes in oxido-redox state in rat liver and kidney

(2012) A Merwid-Ląd et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice

(2012) Robert E. Featherstone et al.   NEUROBIOLOGY OF DISEASE

Effects of the putative antipsychotic alstonine on glutamate uptake in acute hippocampal slices

(2012) Ana P. Herrmann et al.   NEUROCHEMISTRY INTERNATIONAL

Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice

(2012) Manavi Chatterjee et al.   NEUROPHARMACOLOGY

Evaluation of the Antipsychotic Potential of Panax quinquefolium in Ketamine Induced Experimental Psychosis Model in Mice

(2011) Manavi Chatterjee et al.   NEUROCHEMICAL RESEARCH

5-HT2A/C receptors mediate the antipsychotic-like effects of alstonine

(2011) V.M. Linck et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment

(2011) Herbert Y. Meltzer et al.   PSYCHOPHARMACOLOGY

Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data

(2010) Peilin Jia et al.   SCHIZOPHRENIA RESEARCH

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

(2009) Gerhard Gründer et al.   NATURE REVIEWS DRUG DISCOVERY

Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile

(2009) Ozan Pazvantoglu et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis

(2008) Vennila Sreedharan et al.   INVESTIGATIONAL NEW DRUGS